These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4429112

  • 21. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
    [Abstract] [Full Text] [Related]

  • 22. Assessment of possible luteolytic effect on intra-ovarian injection of prostaglandin F-2ALPHA in the human.
    Korda AR, Shutt DA, Smith ID, Shearman RP, Lyneham RC.
    Prostaglandins; 1975 Mar; 9(3):443-9. PubMed ID: 1138301
    [Abstract] [Full Text] [Related]

  • 23. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [Abstract] [Full Text] [Related]

  • 24. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
    Jones GS, Wentz AG.
    Am J Obstet Gynecol; 1972 Oct 01; 114(3):393-404. PubMed ID: 4637460
    [Abstract] [Full Text] [Related]

  • 25. Effects of PGF2alpha and PGF2alpha, 1-15 lactone on the corpus luteum and on early pregnancy in the rhesus monkey.
    Spilman CH, Beuving DC, Forbes AD, Kimball FA.
    Prostaglandins; 1977 Sep 01; 14(3):477-88. PubMed ID: 410075
    [Abstract] [Full Text] [Related]

  • 26. Gonadotropin-sensitive progesterone production by rhesus monkey luteal cells in vitro: a function of age of the corpus luteum during the menstrual cycle.
    Stouffer RL, Nixon WE, Gulyas BJ, Hodgen GD.
    Endocrinology; 1977 Feb 01; 100(2):506-12. PubMed ID: 401732
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Functional evidence for divergent receptor activation mechanisms of luteotrophic and luteolytic events in the human corpus luteum.
    Ottander U, Leung CH, Olofsson JI.
    Mol Hum Reprod; 1999 May 01; 5(5):391-5. PubMed ID: 10338360
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in Rhesus monkeys.
    Bosu WT, Johansson ED.
    Int J Fertil; 1974 May 01; 19(1):28-32. PubMed ID: 4363154
    [Abstract] [Full Text] [Related]

  • 31. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ, Alvarez-Sanchez F, Adejuwon CA, Brache de Mejia V, Leon P, Faundes A.
    Fertil Steril; 1985 Aug 01; 44(2):214-8. PubMed ID: 4018277
    [Abstract] [Full Text] [Related]

  • 32. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct 01; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 33. Effect of HCG on human corpus luteum of menstruation and early gestation.
    Tu BK.
    Endocrinol Jpn; 1978 Dec 01; 25(6):569-74. PubMed ID: 751803
    [Abstract] [Full Text] [Related]

  • 34. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F, Louvet JP, Moatti JP, Smilovici W, Duguet L, Boulard C.
    J Gynecol Obstet Biol Reprod (Paris); 1975 Dec 01; 4(7):915-26. PubMed ID: 767402
    [Abstract] [Full Text] [Related]

  • 35. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 36. Plasma steroid and luteinizing hormone levels during prostaglandin F 2 administration in luteal phase of menstrual cycle.
    Hillier K, Dutton A, Corker CS, Singer A, Embrey MP.
    Br Med J; 1972 Nov 11; 4(5836):333-6. PubMed ID: 4637514
    [Abstract] [Full Text] [Related]

  • 37. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC, Dockery P, Thomas P, Rogers AW, Lenton EA, Cooke ID.
    Fertil Steril; 1988 Nov 11; 50(5):732-42. PubMed ID: 3181485
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effect of prostaglandin F2alpha on corpus luteal function in the rhesus monkey.
    Wan LS, Khatamee M, Neimann W, Feller C, Bigelow B.
    Fertil Steril; 1975 Feb 11; 26(2):111-20. PubMed ID: 1126456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.